Evidence map›Paper›PMID 20351657›Full record

ReviewPediatric research2010

New approaches to neuroprotection in infant heart surgery.

Erin L Albers, David P Bichell, Bethann McLaughlin

Open access · bronzeAbstract readHistorical ArticleReview
In one paragraph

Review in Pediatric research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Noncardiac anomalies in children with congenital heart disease.Frontiers in cardiovascular medicine · 2023
    Article
  4. Article
  5. Article
  6. Heart blood flow simulation: a perspective review.Biomedical engineering online · 2016
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Erin L AlbersDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37323, USA.
David P Bichell
Bethann McLaughlin
Vanderbilt University · USE I L (China) · CN

Funding

THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
CLINICAL PHARMACOLOGY TRAINING PROGRAMT32GM007569 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Bjorn C Knollmann · 1985 to 2026
$12.4M
Cellular Mechanisms of Preconditioning NeuroprotectionR01NS050396 · NINDS · VANDERBILT UNIVERSITY · PI MCLAUGHLIN, BETHANN M · 2005 to 2009
$1.7M
NICHD NIH HHS P30 HD015052NIGMS NIH HHS GM07569-32NIGMS NIH HHS T32 GM007569NINDS NIH HHS NS050396NINDS NIH HHS R01 NS050396
6 · The paper itself

Abstract

Advances in surgical techniques and perioperative management have led to dramatic improvements in outcomes for children with complex congenital heart disease (CHD). As the number of survivors continues to grow, clinicians are becoming increasingly aware that adverse neurodevelopmental outcomes after surgical repair of CHD represent a significant cause of morbidity, with widespread neuropsychologic deficits in as many as 50% of these children by the time they reach school age. Modifications of intraoperative management have yet to measurably impact long-term neurologic outcomes. However, exciting advances in our understanding of the underlying mechanisms of cellular injury and of the events that mediate endogenous cellular protection have provided a variety of new potential targets for the assessment, prevention, and treatment of neurologic injury in patients with CHD. In this review, we will discuss the unique challenges to developing neuroprotective strategies in children with CHD and consider how multisystem approaches to neuroprotection, such as ischemic preconditioning, will be the focus of ongoing efforts to develop new diagnostic tools and therapies. Although significant challenges remain, tremendous opportunity exists for the development of diagnostic and therapeutic interventions that can serve to limit neurologic injury and ultimately improve outcomes for infants and children with CHD.

Indexed as

Cardiac Surgical ProceduresCentral Nervous SystemHeart Defects, CongenitalHistory, 20th CenturyHistory, 21st CenturyHumansInfantInfant, NewbornIschemic PreconditioningNeuroprotective AgentsPostoperative ComplicationsSignal TransductionTime FactorsTreatment OutcomeNeuroprotective Agents

Identifiers

PMID20351657
PMCPMC2921700
OpenAlexW2081028033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.